Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 20, Issue 30, 2014, Pages 10238-10248

  Ali, Ashraf ^a   Abdel Hafiz, Hany ^a   Suhail, Mohd ^a   Al Mars, Amany ^b   Zakaria, Mohammad Khalid ^c   Fatima, Kaneez ^d   Ahmad, Sultan ^a   Azhar, Esam ^a   Chaudhary, Adeel ^a   Qadri, Ishtiaq ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF COLORADO   (United States)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d IQ Institute of Infection and Immunity   (Pakistan)

Author keywords

Activating protein; Apoptosis; Epigenetics; Hepatitis B virus; Hepatocellular carcinoma; Mitogen activated protein kinase; Mutants; Transcription factors; Transforming growth factor; Tumor necrosis factor

Indexed keywords

APOPTOSIS INHIBITOR; HEPATITIS B VIRUS X PROTEIN; MICRORNA; MUTANT PROTEIN; TELOMERASE; TRANSCRIPTION FACTOR; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; DNA DAMAGE; DNA MODIFICATION; ENZYME ACTIVITY; EPIGENETICS; EXCISION REPAIR; GENE EXPRESSION; GENE MUTATION; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS MUTANT; VIRUS MUTATION; VIRUS PATHOGENESIS; ANIMAL; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEPATITIS B; HOST PATHOGEN INTERACTION; LIVER TUMOR; METABOLISM; MUTATION; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER NEOPLASMS; MICRORNAS; MUTATION; TRANS-ACTIVATORS;

EID: 84920272193     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i30.10238     Document Type: Article

References (112)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255 [PMID: 22353262]
2. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007; 13: 74-81 [PMID: 17206756]
3. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491 [PMID: 19224838 DOI: 10.1200/JCO.2008.20.7753]
4. Sun TT, Chu YY. Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. J Cell Physiol Suppl 1984; 3: 39-44 [PMID: 6430924 DOI: 10.1002/jcp.1041210407]
5. Chen X, Dai B, Liu Z, Gao J, Ji Z, Guo J, Chen G, Deng Z, Shao Z. A novel B/C inter-genotype recombinant of hepatitis B virus identified in north-west China. J Gen Virol 2014; 95: 153-155 [PMID: 24129025 DOI: 10.1099/vir.0.054023-0]
6. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol 2004; 78: 12725-12734 [PMID: 15542625 DOI: 10.1128/JVI.78.23.12725-12734.2004]
7. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 2003; 106: 334-341 [PMID: 12845670 DOI: 10.1002/ijc.11254]
8. Tommasi S, Pinto R, Pilato B, Paradiso A. Molecular pathways and related target therapies in liver carcinoma. Curr Pharm Des 2007; 13: 3279-3287 [PMID: 18045179 DOI: 10.2174 /138161207782360663]
9. Kew MC. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26 Suppl 1: 144-152 [PMID: 21199526 DOI: 10.1111/j.1440-1746.2010.06546.x]
10. McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D' Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 2006; 46: 249-279 [PMID: 16854453 DOI: 10.1016/j.advenzreg.2006.01.004]
11. Ng SA, Lee C. Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 2011; 46: 974-990 [PMID: 21647825 DOI: 10.1007/s00535-011-0415-9]
12. Miller RH, Robinson WS. Common evolutionary origin of hepatitis B virus and retroviruses. Proc Natl Acad Sci USA 1986; 83: 2531-2535 [PMID: 3458214 DOI: 10.1073/pnas.83.8.2531]
13. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-660 [PMID: 11686474 DOI: 10.1007/s005350170027]
14. Gong DY, Chen EQ, Huang FJ, Leng XH, Cheng X, Tang H. Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivo. Viruses 2013; 5: 1261-1271 [PMID: 23698398 DOI: 10.3390/v5051261]
15. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 1997; 57: 5137-5142 [PMID: 9371515]
16. Becker SA, Lee TH, Butel JS, Slagle BL. Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 1998; 72: 266-272 [PMID: 9420223]
17. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 2007; 252: 157-170 [PMID: 17188425 DOI: 10.1016/j.canlet.2006.11.010]
18. Diao J, Garces R, Richardson CD. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 2001; 12: 189-205 [PMID: 11325602 DOI: 10.1016/S1359-6101(00)00034-4]
19. Qadri I, Fatima K, AbdeL-Hafiz H. Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol 2011; 11: 48 [PMID: 21375739 DOI: 10.1186/1471-2180-11-48]
20. Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 1996; 15: 261-269 [PMID: 8634084]
21. Bellamy CO, Clarke AR, Wyllie AH, Harrison DJ. p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J 1997; 11: 591-599 [PMID: 9212083]
22. Lee TH, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 1995; 69: 1107-1114 [PMID: 7815490]
23. Capovilla A, Carmona S, Arbuthnot P. Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem Biophys Res Commun 1997; 232: 255-260 [PMID: 9125143 DOI: 10.1006/bbrc.1997.6269]
24. Qadri I, Conaway JW, Conaway RC, Schaack J, Siddiqui A. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci USA 1996; 93: 10578-10583 [PMID: 8855220 DOI: 10.1073/pnas.93.20.10578]
25. Groisman IJ, Koshy R, Henkler F, Groopman JD, Alaoui-Jamali MA. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis 1999; 20: 479-483 [PMID: 10190565 DOI: 10.1093/carcin/20.3.479]
26. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA 1995; 92: 11215-11219 [PMID: 7479968 DOI: 10.1073/pnas.92.24.11215]
27. Lee YI, Lee S, Lee Y, Bong YS, Hyun SW, Yoo YD, Kim SJ, Kim YW, Poo HR. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4. Oncogene 1998; 16: 2367-2380 [PMID: 9620554 DOI: 10.1038/sj.onc.1201760]
28. Dewantoro O, Gani RA, Akbar N. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. Acta Med Indones 2006; 38: 154-159 [PMID: 16953033]
29. Madden CR, Finegold MJ, Slagle BL. Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol 2002; 76: 11770-11774 [PMID: 12388740 DOI: 10.1128/JVI.76.22.11770-11774.2002]
30. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995; 10: 1053-1059 [PMID: 7700629]
31. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998; 17: 2115-2123 [PMID: 9798683 DOI: 10.1038/sj.onc.1202432]
32. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998; 273: 381-385 [PMID: 9417092 DOI: 10.1074/jbc.273.1.381]
33. Miao J, Chen GG, Chun SY, Lai PP. Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett 2006; 236: 115-124 [PMID: 15990224 DOI: 10.1016/j.canlet.2005.05.014]
34. Ye L, Dong N, Wang Q, Xu Z, Cai N, Wang H, Zhang X. Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene. Intervirology 2008; 51: 50-58 [PMID: 18334850 DOI: 10.1159/000120289]
35. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995; 55: 6012-6016 [PMID: 8521383]
36. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997; 94: 14707-14712 [PMID: 9405677 DOI: 10.1073/pnas.94.26.14707]
37. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995; 9: 41-47 [PMID: 7704023 DOI: 10.1038/ng0195-41]
38. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91: 2230-2234 [PMID: 8134379 DOI: 10.1073/pnas.91.6.2230]
39. Lee YI, Kang-Park S, Do SI, Lee YI. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 2001; 276: 16969-16977 [PMID: 11278872 DOI: 10.1074/jbc.M011263200]
40. Kuo TC, Chao CC. Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. Biochem Pharmacol 2010; 80: 1093-1102 [PMID: 20541537 DOI: 10.1016/j.bcp.2010.06.003]
41. Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis. Biochem Biophys Res Commun 2008; 374: 175-180 [PMID: 18601905 DOI: 10.1016/j.bbrc.2008.06.098]
42. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997; 94: 8744-8749 [PMID: 9238048 DOI: 10.1073/pnas.94.16.8744]
43. Chan DW, Ng IO. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. J Pathol 2006; 208: 372-380 [PMID: 16353167 DOI: 10.1002/path.1901]
44. Liu YG, Liu SX, Liang XH, Zhang Q, Gao LF, Han LH, Cao YL, Hou N, Du J, Sun WS. Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model. Biochem Biophys Res Commun 2007; 352: 329-334 [PMID: 17126290 DOI: 10.1016/j.bbrc.2006.11.024]
45. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001; 61: 7803-7810 [PMID: 11691796]
46. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003; 163: 1101-1107 [PMID: 12937151 DOI: 10.1016/S0002-9440(10)63469-4]
47. Tian Y, Yang W, Song J, Wu Y, Ni B. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 2013; 33: 2810-2816 [PMID: 23716588 DOI: 10.1128/MCB.00205-13]
48. Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 2014; 342: 223-230 [PMID: 22306342 DOI: 10.1016/j.canlet.2012.01.038]
49. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005; 24: 6617-6625 [PMID: 16007161 DOI: 10.1038/sj.onc.1208827]
50. Liu J, Lian Z, Han S, Waye MM, Wang H, Wu MC, Wu K, Ding J, Arbuthnot P, Kew M, Fan D, Feitelson MA. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 2006; 25: 1008-1017 [PMID: 16247464 DOI: 10.1038/sj.onc.1209138]
51. Jung JK, Arora P, Pagano JS, Jang KL. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res 2007; 67: 5771-5778 [PMID: 17575144 DOI: 10.1158/0008-5472.CAN-07-0529]
52. Zhu R, Li BZ, Li H, Ling YQ, Hu XQ, Zhai WR, Zhu HG. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Pathol Int 2007; 57: 328-336 [PMID: 17539963 DOI: 10.1111/j.1440-1827.2007.02104.x]
53. Zhu YZ, Zhu R, Fan J, Pan Q, Li H, Chen Q, Zhu HG. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J Viral Hepat 2010; 17: 98-107 [PMID: 19732323 DOI: 10.1111/j.1365-2893.2009.01156.x]
54. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007; 132: 1476-1494 [PMID: 17408664 DOI: 10.1053/j.gastro.2007.01.034]
55. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001; 8: 781-794 [PMID: 11684014 DOI: 10.1016/S1097-2765(01)00367-7]
56. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 2010; 51: 142-153 [PMID: 20034025 DOI: 10.1002/hep.23247]
57. Jung JK, Park SH, Jang KL. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation. J Gen Virol 2010; 91: 493-500 [PMID: 19828754 DOI: 10.1099/vir.0.015149-0]
58. Niu D, Zhang J, Ren Y, Feng H, Chen WN. HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells. Mol Oncol 2009; 3: 67-76 [PMID: 19383368 DOI: 10.1016/j.molonc.2008.10.002]
59. Yokota T, Suda T, Igarashi M, Kuroiwa T, Waguri N, Kawai H, Mita Y, Aoyagi Y. Telomere length variation and maintenance in hepatocarcinogenesis. Cancer 2003; 98: 110-118 [PMID: 12833463 DOI: 10.1002/cncr.11428]
60. Zhang X, Dong N, Zhang H, You J, Wang H, Ye L. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 2005; 145: 98-104 [PMID: 15746653 DOI: 10.1016/j.lab.2004.11.018]
61. Liu YC, Chen CJ, Wu HS, Chan DC, Yu JC, Yang AH, Cheng YL, Lee SC, Harn HJ. Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 2004; 30: 384-390 [PMID: 15063891 DOI: 10.1016/j.ejso.2004.01.003]
62. Su JM, Lai XM, Lan KH, Li CP, Chao Y, Yen SH, Chang FY, Lee SD, Lee WP. X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter. Hepatology 2007; 46: 402-413 [PMID: 17559154 DOI: 10.1002/hep.21675]
63. Her S, Bell RA, Bloom AK, Siddall BJ, Wong DL. Phenylethanolamine N-methyltransferase gene expression. Sp1 and MAZ potential for tissue-specific expression. J Biol Chem 1999; 274: 8698-8707 [PMID: 10085109 DOI: 10.1074/jbc.274.13.8698]
64. Qu ZL, Zou SQ, Cui NQ, Wu XZ, Qin MF, Kong D, Zhou ZL. Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells. World J Gastroenterol 2005; 11: 5627-5632 [PMID: 16237755]
65. Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 2006; 25: 3823-3833 [PMID: 16799624 DOI: 10.1038/sj.onc.1209559]
66. Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 1993; 195: 305-314 [PMID: 8337816 DOI: 10.1006/viro.1993.1381]
67. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G. Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 1996; 70: 641-646 [PMID: 8523586]
68. Kim HR, Lee SH, Jung G. The hepatitis B viral X protein activates NF-kappaB signaling pathway through the up-regulation of TBK1. FEBS Lett 2010; 584: 525-530 [PMID: 19958770 DOI: 10.1016/j.febslet.2009.11.091]
69. Andrisani OM, Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review). Int J Oncol 1999; 15: 373-379 [PMID: 10402250]
70. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994; 91: 10350-10354 [PMID: 7937954 DOI: 10.1073/pnas.91.22.10350]
71. Benn J, Su F, Doria M, Schneider RJ. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogenactivated protein kinases. J Virol 1996; 70: 4978-4985 [PMID: 8764004]
72. Um HR, Lim WC, Chae SY, Park S, Park JH, Cho H. Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells. Virus Res 2007; 125: 1-8 [PMID: 17188775 DOI: 10.1016/j.virusres.2006.11.007]
73. Liu LP, Liang HF, Chen XP, Zhang WG, Yang SL, Xu T, Ren L. The role of NF-kappaB in Hepatitis b virus X proteinmediated upregulation of VEGF and MMPs. Cancer Invest 2010; 28: 443-451 [PMID: 20073580 DOI: 10.3109/0735790090 3405959]
74. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999; 18: 4848-4859 [PMID: 10490818 DOI: 10.1038/sj.onc.1202867]
75. Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Int J Cancer 2014; 134: 1638-1647 [PMID: 24122375 DOI: 10.1002/ijc.28501]
76. Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, Zhang X. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Neoplasia 2013; 15: 1282-1291 [PMID: 24339740]
77. Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 2013; 25: 1037-1043 [PMID: 23376496 DOI: 10.1016/j.cellsig.2013.01.019]
78. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest 2013; 123: 630-645 [PMID: 23321675 DOI: 10.1172/JCI64265]
79. Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013; 32: 3296-3305 [PMID: 23604124 DOI: 10.1038/onc.2013.150]
80. Chen YJ, Chien PH, Chen WS, Chien YF, Hsu YY, Wang LY, Chen JY, Lin CW, Huang TC, Yu YL, Huang WC. Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells. Evid Based Complement Alternat Med 2013; 2013: 682380 [PMID: 23840262 DOI: 10.1155/2013/682380]
81. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 2011; 105: 146-153 [PMID: 21629246 DOI: 10.1038/bjc.2011.190]
82. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52: 60-70 [PMID: 20578129 DOI: 10.1002/hep.23660]
83. Fu X, Tan D, Hou Z, Hu Z, Liu G. miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1. Int J Mol Sci 2012; 13: 8514-8539 [PMID: 22942717 DOI: 10.3390/ijms13078514]
84. Fu X, Tan D, Hou Z, Hu Z, Liu G, Ouyang Y, Liu F. The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation. PLoS One 2012; 7: e43204 [PMID: 22912826 DOI: 10.1371/journal.pone.0043204]
85. Xie QH, He XX, Chang Y, Jiang X, Lin JS. [HBx gene downregulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2]. Zhonghua Gan Zang Bing Za Zhi 2011; 19: 857-860 [PMID: 22433310 DOI: 10.3760/cma. j.issn.1007-3418.2011.11.015]
86. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995; 21: 313-321 [PMID: 7843699 DOI: 10.1002/hep.1840210208]
87. Wang WL, London WT, Feitelson MA. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 1991; 51: 4971-4977 [PMID: 1654208]
88. Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. J Clin Virol 2005; 34: 7-12 [PMID: 16087118 DOI: 10.1016/j.jcv.2005.01.006]
89. Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D, Bréchot C, Thiers V. Characterisation of hepatitis B virus X protein mutants in tumour and nontumour liver cells using laser capture microdissection. J Hepatol 2003; 39: 253-261 [PMID: 12873823 DOI: 10.1016/S0168-8278(03)00217-4]
90. Guo X, Jin Y, Qian G, Tu H. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 2008; 49: 718-725 [PMID: 18801591 DOI: 10.1016/j.jhep.2008.06.026]
91. Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D, Schirmacher P, Bréchot C, Paterlini Bréchot P. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 1999; 80: 497-505 [PMID: 9935147 DOI: 10.1002/(SICI)1097-0215(19990209)804<497:: AID-IJC3>3.0.CO;2-8]
92. Liu L, Li Y, Zhang S, Yu D, Zhu M. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells. Oncol Rep 2012; 27: 168-173 [PMID: 21956590 DOI: 10.3892/or.2011.1478]
93. Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res 2008; 14: 5061-5068 [PMID: 18698024 DOI: 10.1158/1078-0432.CCR-07-5082]
94. Kumar V, Jayasuryan N, Kumar R. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci USA 1996; 93: 5647-5652 [PMID: 8643631 DOI: 10.1073/pnas.93.11.5647]
95. Liu X, Wang L, Zhang S, Lin J, Zhang S, Feitelson MA, Gao H, Zhu M. Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis 2008; 29: 1207-1214 [PMID: 18477650 DOI: 10.1093/carcin/bgn111]
96. Wang Q, Zhang T, Ye L, Wang W, Zhang X. Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China. Cancer Epidemiol 2012; 36: 369-374 [PMID: 22178505 DOI: 10.1016/j.canep.2011.11.006]
97. Wang Q, Zhang WY, Ye LH, Zhang XD. A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase. Acta Pharmacol Sin 2010; 31: 367-374 [PMID: 20173757 DOI: 10.1038/aps.2010.5]
98. Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM, Cavalli LR, Haddad BR, Harris CC. Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocytederived cell line. Int J Cancer 2010; 127: 1011-1020 [PMID: 20017137 DOI: 10.1002/ijc.25118]
99. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428 [PMID: 1849234 DOI: 10.1038/350427a0]
100. Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, Raimondo G, Levrero M. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA 2009; 106: 19975-19979 [PMID: 19906987 DOI: 10.1073/pnas.0908365106]
101. Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 2000; 19: 5213-5220 [PMID: 11077437 DOI: 10.1038/sj.onc.1203903]
102. Hsia CC, Yuwen H, Tabor E. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet 1996; 348: 625-626 [PMID: 8774611 DOI: 10.1016/S0140-6736(05)64851-9]
103. Hsia CC, Nakashima Y, Tabor E. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 1997; 241: 726-729 [PMID: 9434776 DOI: 10.1006/bbrc.1997.7882]
104. Wang Q, Zhang W, Liu Q, Zhang X, Lv N, Ye L, Zhang X. A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia 2010; 12: 103-115 [PMID: 20126469]
105. Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, Zhao L, Murakami S. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005; 79: 5548-5556 [PMID: 15827169 DOI: 10.1128/JVI.79.9.5548-5556.2005]
106. Lin X, Xu X, Huang QL, Liu YQ, Zheng DL, Chen WN, Lin JY. Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated. World J Gastroenterol 2005; 11: 4703-4708 [PMID: 16094714]
107. Tangkijvanich P, Sa-Nguanmoo P, Mahachai V, Theamboonlers A, Poovorawan Y. A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma. Hepatol Int 2010; 4: 577-584 [PMID: 21063480 DOI: 10.1007/s12072-010-9197-z]
108. Zhang H, Shan CL, Li N, Zhang X, Zhang XZ, Xu FQ, Zhang S, Qiu LY, Ye LH, Zhang XD. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation. Acta Pharmacol Sin 2008; 29: 473-480 [PMID: 18358094 DOI: 10.1111/j.1745-7254.2008.00764.x]
109. Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, Groopman J, Chemin I, Hainaut P. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis 2012; 33: 1219-1224 [PMID: 22759751 DOI: 10.1093/carcin/bgs135]
110. Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y, Shao RX, Dharel N, Tanaka Y, Ohta M, Tateishi R, Shiina S, Tatsukawa M, Fukai K, Imazeki F, Yokosuka O, Shiratori Y, Omata M. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol 2006; 45: 805-812 [PMID: 17050029 DOI: 10.1016/j.jhep.2006.07.025]
111. Kwun HJ, Jang KL. Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclindependent kinase inhibitor p21 gene. Nucleic Acids Res 2004; 32: 2202-2213 [PMID: 15107488 DOI: 10.1093/nar/gkh553]
112. Qadri I, Maguire HF, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 1995; 92: 1003-1007 [PMID: 7862623 DOI: 10.1073/pnas.92.4.1003]